Despite numerous similarities in basic cellular mechanisms, there are important differences between HSC of mice and humans in specific roles of transcription factors and cellular behavior such as cycling and DNA damage responses. For instance, mouse HSC have been described as dividing once every 30–50 days whereas human HSC tend to be more quiescent, dividing every 175–350 days. In humans, HSC and hematopoietic progenitor cells (HPC) do not express CD150, and CD48 is expressed by both HSC and HPC6. Human long term HSC activity resides in the CD34+CD38−lin- fraction of cord blood and bone marrow, which expresses the cytokine receptor Flt-3. Murine HSC on the other hand do not express either CD34 or Flt-3, and do express CD38. These immunophenotypic differences may signify functional differences in stem cell maintenance, differentiation, and microenvironmental interaction pathways, between murine and human hematopoiesis. CD150, a member of the signaling lymphocyte activation molecule (SLAM) family has been suggested to play a role in the maintenance of the murine HSC niche11 In mice, Flt-3 signaling is important for lymphopoiesis but not for HSC survival or myelopoiesis. Kit Ligand has been shown to be a more potent survival factor than Flt3 ligand in vitro for mouse bone marrow HSC, but the opposite appears to be true for human HSC.The species difference in the effects of cytokines on survival of HSC in vitro has important implications for the design of systems for ex vivo expansion and transduction of human HSC.
The science of toxicology is based on the principle that there is a relationship between a toxic reaction (the response) and the amount of poison received (the dose). The toxic effects on an organism are related to the amount of exposure. toxicity can ensue when exposure exceeds a certain dose and/or time. The normal therapeutic range of drug dosage is very narrow and the wider spectrum of acute toxic effects can only be studied in cases of overdosage. toxicity occurred due to specific chemicals, and the body’s response to the chemicals depended on the dose. and conversely substances considered toxic can be less harmful or even beneficial at lower doses. Safe doses for a variety of chemicals in humans have been legally set.
Target selection: the process of selecting a single object from a field of multiple objects as the goal of a movement. To select a proposed research target, a range of issues need evaluation. Perhaps most important is what constitutes an improved medicine. Target selection in drug discovery — defined here as the decision to focus on finding an agent with a particular biological action that is anticipated to have therapeutic utility is influenced by a complex balance of scientific, medical and strategic considerations